Literature DB >> 31810382

Clinical and laboratory parameters, risk factors predisposing to the development of priapism in sickle cell patients.

Salam Alkindi1,2, Said S Almufargi1, Anil Pathare1.   

Abstract

Entities:  

Keywords:  Sickle cell disease; erectile dysfunction; priapism; risk factors

Mesh：

Substances：

Year:  2019        PMID： 31810382      PMCID： PMC6987744          DOI： 10.1177/1535370219892846

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN： 1535-3699


× No keyword cloud information.
  41 in total

1.  Post-splenectomy veno-occlusive priapism in a child with idiopathic thrombocytopenic purpura.

Authors:  Eitan M Gross; Phillip D Levin; Ezekiel H Landau
Journal:  Isr Med Assoc J       Date:  2002-11       Impact factor: 0.892

2.  Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality.

Authors:  Gregory J Kato; Sabrina Martyr; William C Blackwelder; James S Nichols; Wynona A Coles; Lori A Hunter; Marie-Luise Brennan; Stanley L Hazen; Mark T Gladwin
Journal:  Br J Haematol       Date:  2005-09       Impact factor: 6.998

Review 3.  The alpha4beta1 integrin in sickle cell disease.

Authors:  J E Brittain; L V Parise
Journal:  Transfus Clin Biol       Date:  2008-05-23       Impact factor: 1.406

4.  Priapism in the United States: the changing role of sickle cell disease.

Authors:  Kristin L Chrouser; Onaopemipo B Ajiboye; Tolulope A Oyetunji; David C Chang
Journal:  Am J Surg       Date:  2011-04       Impact factor: 2.565

5.  Hemolysis-associated priapism in sickle cell disease.

Authors:  Vikki G Nolan; Diego F Wyszynski; Lindsay A Farrer; Martin H Steinberg
Journal:  Blood       Date:  2005-06-28       Impact factor: 22.113

6.  Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea.

Authors:  Nicola Conran; André Fattori; Sara T O Saad; Fernando F Costa
Journal:  Am J Hematol       Date:  2004-08       Impact factor: 10.047

7.  Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death.

Authors:  Gregory J Kato; Zeneng Wang; Roberto F Machado; William C Blackwelder; James G Taylor; Stanley L Hazen
Journal:  Br J Haematol       Date:  2008-03-17       Impact factor: 6.998

Review 8.  Hydroxyurea therapy for priapism prevention and erectile function recovery in sickle cell disease: a case report and review of the literature.

Authors:  Uzoma A Anele; A Kyle Mack; Linda M S Resar; Arthur L Burnett
Journal:  Int Urol Nephrol       Date:  2014-05-14       Impact factor: 2.370

9.  Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

Authors:  Mark T Gladwin; Vandana Sachdev; Maria L Jison; Yukitaka Shizukuda; Jonathan F Plehn; Karin Minter; Bernice Brown; Wynona A Coles; James S Nichols; Inez Ernst; Lori A Hunter; William C Blackwelder; Alan N Schechter; Griffin P Rodgers; Oswaldo Castro; Frederick P Ognibene
Journal:  N Engl J Med       Date:  2004-02-26       Impact factor: 91.245

Review 10.  Prevalence and Characteristics of Priapism in Sickle Cell Disease.

Authors:  Giovanna A O Arduini; Alessandra B Trovó de Marqui
Journal:  Hemoglobin       Date:  2018-05-10       Impact factor: 0.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.